Display Settings:

Format

Send to:

Choose Destination
Breast Cancer Res. 2011;13(6):228. doi: 10.1186/bcr2940. Epub 2011 Nov 1.

Clinical relevance and biology of circulating tumor cells.

Author information

  • 1Department of Tumour Biology, University Medical Centre Hamburg-Eppendorf, Martinistr, 52, 20246 Hamburg, Germany.

Abstract

Most breast cancer patients die due to metastases, and the early onset of this multistep process is usually missed by current tumor staging modalities. Therefore, ultrasensitive techniques have been developed to enable the enrichment, detection, isolation and characterization of disseminated tumor cells in bone marrow and circulating tumor cells in the peripheral blood of cancer patients. There is increasing evidence that the presence of these cells is associated with an unfavorable prognosis related to metastatic progression in the bone and other organs. This review focuses on investigations regarding the biology and clinical relevance of circulating tumor cells in breast cancer.

PMID:
22114869
[PubMed - indexed for MEDLINE]
PMCID:
PMC3326546
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk